Resources Repository
-
ReportPublication 2016Modeling to Inform Strategies to Improve Population Health
This workshop report summarizes a workshop convened by the Institute of Medicine to explore the potential …
This workshop report summarizes a workshop convened by the Institute of Medicine to explore the potential uses of simulation and other types of modeling for improving health. Participants worked to identify how modeling could inform population health decision making (selecting and refining potential strategies, ranging from interventions to investments) based on lessons learned from models that have been, or have not been, used successfully, opportunities and barriers to incorporating models into decision making, and data needs and…
Microsimulation | Decision Analysis | North America | Health Systems | Mathematical Models | State-Transition | Dynamic Simulation | Chronic Disease/Risk | Environmental Health | Policy/Regulation | Business/Industry | Climate/Environment | Government/Law | Health/Medicine -
ReportPublication 2021What the American Public Thinks About Vaccines and How Framing Can Help
This paper explores the question of public understandings, beliefs, and attitudes about vaccination in general, …
This paper explores the question of public understandings, beliefs, and attitudes about vaccination in general, and childhood vaccination more specifically. The authors provide an overview of the existing literature on public thinking about vaccination and on effective communication strategies and interventions that have been either suggested or empirically tested. This description was extracted from the publication abstract.
Preferences/Values | North America | Child/Nutrition | Infectious Diseases | Social Determinants | Culture/Society | Health/Medicine | Science/Technology -
ReportPublication 2015Returns on HTA Funded Research
This report from the RAND Corporation dissects the impact of the Health Technology Assessment (HTA) …
This report from the RAND Corporation dissects the impact of the Health Technology Assessment (HTA) program in making quality research accessible and cost-effective. The authors conduct an economic analysis to illustrate benefits of new interventions in two ways: through improved health, measured in QALYs, and through showing that the intervention allows for the same health outcome and a lower cost. The report utilizes economic analyses and case studies to make recommendations. These recommendations include considering…
Costing Methods | Europe | Health Systems | Health Outcomes | Evidence Synthesis | Economics/Finance | Health/Medicine | Science/Technology -
ReportPublication 2015Opioid Dependence: Final Report
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value …
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value of interventions for the management of opioid dependence. The goals of the report are to document the federal and New England state regulations affecting treatment options, provide an overview of existing clinical guidelines and payer coverage policies, and summarize the evidence on the different management approaches for opioid dependence, including special considerations for adolescents. An appendix is provided by ICER.…
Preferences/Values | North America | Health Systems | Health Outcomes | Evidence Synthesis | Cost-Effectiveness Analysis | Technology Assessment | Chronic Disease/Risk | Mental Health | Policy/Regulation | Business/Industry | Government/Law | Health/Medicine | Science/Technology -
ReportPublication 2014Redirecting Innovation in U.S. Health Care
This report from RAND Health explores methods of reducing health care spending and developing medical …
This report from RAND Health explores methods of reducing health care spending and developing medical products that provide cost value with health benefits. It summarizes literature and explores case studies to provide policy recommendations to meet these goals. It identifies a wide range of factors that affect the costs, risks, and rewards of medical product invention. Some of these features include treatment creep, the medical arms race, costs and risks of FDA approval, limited reward…
Costing Methods | North America | Health Systems | Health Outcomes | Evidence Synthesis | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | Science/Technology